Squarepoint Ops LLC Viking Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 34,254 shares of VKTX stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,254

Previous 141,820 75.85%

Holding current value

$1.45 Million

Previous $7.52 Million 71.16%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$49.84 - $70.47 $5.36 Million - $7.58 Million	-107,566 Reduced 75.85%	34,254 $2.17 Million
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $6.72 Million - $11.4 Million	141,820 New	141,820 $7.52 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $467,571 - $993,842	50,603 New	50,603 $941,000
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $210,589 - $451,671	26,063 New	26,063 $433,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $3.89 $971 - $1,482	-381 Reduced 2.58%	14,382 $39,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $6,492 - $9,692	-3,077 Reduced 17.25%	14,763 $43,000
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $150,837 - $245,361	-50,279 Reduced 73.81%	17,840 $54,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $173,438 - $253,370	37,704 Added 123.97%	68,119 $313,000
Q3 2021 Nov 15, 2021	SELL	$5.58 - $7.04 $383,630 - $484,007	-68,751 Reduced 69.33%	30,415 $191,000
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $36,791 - $47,708	-7,089 Reduced 6.67%	99,166 $594,000
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $355,346 - $598,640	61,907 Added 139.59%	106,255 $672,000
Q4 2020 Feb 16, 2021	SELL	$5.3 - $6.71 $293,280 - $371,304	-55,336 Reduced 55.51%	44,348 $250,000
Q3 2020 Nov 16, 2020	BUY	$5.73 - $8.11 $571,189 - $808,437	99,684 New	99,684 $580,000
Q1 2020 May 15, 2020	SELL	$3.45 - $7.95 $380,697 - $877,258	-110,347 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $190,557 - $260,747	29,868 Added 37.11%	110,347 $885,000
Q3 2019 Nov 14, 2019	SELL	$6.55 - $8.6 $361,815 - $475,055	-55,239 Reduced 40.7%	80,479 $554,000
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $652,855 - $904,804	85,118 Added 168.22%	135,718 $1.13 Million
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $192,099 - $251,909	-25,343 Reduced 33.37%	50,600 $503,000
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $543,751 - $1.23 Million	75,943 New	75,943 $581,000

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Viking Therapeutics, Inc. Transaction History